Search

The University of Tokyo, Internet Initiative Japan (IIJ), APRESIA, and Fujitsu Limited have successfully developed Open Source Software for the Private 5G/6G Mobile System, realizing a domestically produced, low-cost 5G [...]

Pune: Quince Market Insights has issued the following news release: According to a recent market study by Quince Market Insights, the global Electrochemical Instrument Market Size is estimated at 14,024.7 [...]

TOKYO: Kioxia Corporation has issued the following news release: Kioxia Corporation, a world leader in memory solutions, announced today that its employees received the Award for Science and Technology from [...]

M2 PRESSWIRE-April 20, 2023-: Narcolepsy Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies - NLS Pharma, Vallon Pharma, Takeda, Axsome therapeutics (C)1994-2023 M2 [...]

Japan, April 19 -- Kioxia Corporation, a world leader in memory solutions, announced today that its employees received the Award for Science and Technology from The Commendation for Science and [...]

TOKYO -- Kioxia Corporation, a world leader in memory solutions, announced today that its employees received the Award for Science and Technology from The Commendation for Science and Technology by [...]

Dublin: Research and Markets has issued the following press release: The 'Global Glycomics Market: Analysis By Product, By Application, By End-User, By Region Size and Trends with Impact of COVID-19 [...]

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Global Glycomics Market: Analysis By Product, By Application, By End-User, By Region Size and Trends with Impact of COVID-19 [...]

Burlingame, April 13, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global https://www.globenewswire.com/Tracker?data=KRhAPmNIAC3QPXfou-Z856M-yFn1d2jmTQm1El7813T_qhEHbAzAoTq6k3T-wTeeZLgKeUQzEf9G5DHja01FgJ4Q3LHCZcHbE3VS-MA6b4D_bMBBKu3ahIWZl6UOD8g6hs-MH0wzC7lGDlmbAEXvP0ROuMf3gT-3eXolj1HF3XQlH0go3XgB3Qtz7FJ37ASv is estimated to be valued at US$ 53.0 million in 2023 and is expected to [...]

Tenders are invited for Periodical services to certain buildings in uarf kulamavu under age i r and d Doc Fees : INR 500.00 Tender Category : Services Earnest Money : [...]

Tenders are invited for Repair maintenance of steel gates wicket gates rolling shutters gate pillars garages flooring and certain misc b and r works under age i r and d [...]

TOKYO, bitBiome, Inc. (Head office: Shinjuku-ku, Tokyo; President: Yuji Suzuki; hereafter bitBiome) and Kaken Pharmaceuticals (Head office: Bunkyo-ku, Tokyo; President: Hiroyuki Horiuchi; hereafter Kaken) have signed a joint research agreement [...]

TOKYO, March 30, 2023 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment totaling approximately 400 million yen (US$2.9 million[sup.1]) for the research and development of [...]

Tenders are invited for Repair replacement of external water supply pipe lines, control valves, valve chamber and connected works at technical and residential area, npol kochi under agei r and [...]

Tenders are invited for Term contract for artificers works for 14 afc kakkanad under age i r and d kochi Doc Fees : INR 500.00 Tender Category : Works Earnest [...]

Tenders are invited for Term contract for artificers works for technical area of npol under age i r and d kochi Doc Fees : INR 500.00 Tender Category : Works [...]

Tenders are invited for Term contract for artificers works for residential area of npol under age i r and d kochi Doc Fees : INR 500.00 Tender Category : Works [...]

Shionogi & Co Ltd announced that Shionogi has entered into a collaboration agreement to create new drugs for malaria with Nagasaki University and the not-for-profit research and development organization, Medicines for Malaria Venture (hereafter 'MMV'). This collaboration that MMV has now joined will be funded by the Global Health Innovative Technology Fund (hereafter 'GHIT Fund'). Shionogi has entered into a comprehensive cooperation agreement with Nagasaki University, pursuing research for the prevention, treatment of malaria. With the addition of MMV, this collaboration will pursue new malaria drugs and seek to create development candidate compounds. MMV is an international non-profit organization that is involved in the development of malaria drugs around the world, and this new collaboration will allow us to accelerate the evaluation and the development of candidate compounds. Original source: Shionogi Inc, website: http://www.shionogi.com/, Copyright Shionogi Inc 2023., joint venture; research and development; antimalarials; Shionogi & [...]

TOKYO, March 13, 2023 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment totaling approximately 260 million yen (US$1.9 million[sup.1]) for the research and development of [...]

LA JOLLA, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock [...]

The Global Health Innovative Technology Fund (GHIT Fund) and?Unitaid?have signed a cooperation framework that aims to strengthen collaboration between the two agencies to increase cooperation between the Japanese research and [...]

(GlobeNewswire) - The 'Elotuzumab Emerging Drug Insight and Market Forecast - 2032' drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights about Elotuzumab for AL Amyloidosis [...]

Toray Industries Inc announced on 16 Feb 2023 that it has developed a rapid integrated moulding technology for carbon fibre reinforced plastic (CFRP) mobility components. This material sandwiches a light, porous carbon fibre-reinforced foam (CFRF) core with a thermosetting prepreg skin offering outstanding mechanical properties. Toray obtained some findings for this advance under the New Energy and Industrial Technology Development Organization's Research and Development of Innovative Structural Materials project. This new technology makes it possible to mould such CFRP mobility components as a car roof 10 times faster than a conventional autoclave moulding setup. Such offerings can be just half the weight of steel counterparts. Toray will keep pursuing R&D to accelerate the application of this technology to electrified vehicle parts, for which lightness and fast production are vital. CFRF offers significantly better strength, elastic modulus, and impact resistance than conventional core materials. Its low specific gravity range of 0.2 to 0.4 can enhance performance and lighten sandwich structures. Toray demonstrated its concept by using a pressing machine to create a large automobile roof panel (1.2 m long x 1.2 m wide x 2.3 mm thick) in just five minutes. This was 10-fold faster than the conventional approach. The company assessed rigidity tests, coatability, sound insulation properties, and other practical aspects for automobile production. In vital drop-weight impact tests, Toray confirmed that the skin core interface did not delaminate and that impact absorption is excellent. Toray will undertake R&D to meet wide-ranging needs by offering this setup for simultaneously saving weight and accelerating production. The company also looks to cultivate such emerging transportation modalities as urban air mobility and drones that benefit massively from lightweight materials. Original source: Toray Industries, website: http://www.toray.com/, Copyright Toray Industries Inc 2023., FRP; new technology or process; research and development; carbon fibre; fibre reinforced plastics; foamed plastics; prepregs; thermosetting resins; Toray [...]

Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The https://www.researchandmarkets.com/reports/5214336/elotuzumab-emerging-drug-insight-and-market?utm_source=GNOM&utm_medium=PressRelease&utm_code=qvz4mr&utm_campaign=1821127+-+Elotuzumab+Emerging+Drug+Insight+and+Market+Forecast+2022-2032%3a+Comprehensive+Analysis+on+Drug+Mechanisms%2c+R%26D+Activities%2c+Key+Players+and+Emerging+Therapies&utm_exec=como322prd drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights about Elotuzumab for AL Amyloidosis in the 7MM. [...]

2023 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on esophagectomy is now available. According to news reporting originating [...]

2023 JUN 14 (VerticalNews) -- By a News Reporter-Staff News Editor at Computer Weekly News -- New research on Oncology - Gastric Cancer is the subject of a report. According [...]

2023 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at OBGYN & Reproduction Week -- Research findings on carcinomas are discussed in a new report. According to news [...]

2023 JUN 5 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Current study results on infectious diseases and conditions have been published. According to news [...]

2023 MAY 22 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators discuss new findings in siRNA-based therapy. According to news reporting out of Saitama, Japan, [...]

2023 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on colon cancer have been published. According to news reporting from the [...]

SAN CLEMENTE, Calif.: Swift Tactical Systems has issued the following news release: Swift Engineering announced its Japanese Subsidiary, Swift Xi, signed an agreement with Japan's New Energy and Industrial Technology [...]

SAN CLEMENTE, Calif., Jan. 18, 2023 /PRNewswire/ -- Swift Engineering announced its Japanese Subsidiary, Swift Xi, signed an agreement with Japan's New Energy and Industrial Technology Development Organization (NEDO) in [...]

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Global Single Cell Genomics Market Forecasts by End-user & Technology with Executive & Consultant Guides, Including Customized Forecasting and [...]

Okuma, Futaba, Namie, and Toyota Motor Corporation (Toyota) on December 22 entered a Carbon Neutrality Partnership Agreement. The three towns of Okuma, Futaba, and Namie are located in the Futaba [...]

India, Dec. 17 -- DENSO, a leading mobility supplier, has hosted its annual Dialog Day on December 15th. Aiming to enhance its concepts 'Green' and 'Peace of Mind' to realize [...]

M2 PRESSWIRE-December 8, 2022-: Hematopoietic Stem Cell Transplantation (HSCT) Market to Observe Stupendous Growth During the Forecast Period (2022-2032), Investigates DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:07122022 As per DelveInsight, the Hematopoietic [...]

Moving forward to a communications network that maximizes the use of the cloud for communications infrastructure in the post-5G era TOKYO, Nov 24, 2022 - (JCN Newswire) - The University [...]

Tenders are invited for Repairs to internal electrification and replacement of unserviceable em fittings at npol under age i r and d kochi Doc Fees : INR 500.00 Tender Category [...]

M2 PRESSWIRE-November 11, 2022-: Chronic Gout Market to Register Sustainable Growth During the Forecast Period (2022-32) - DelveInsight | Key Companies - Atom Bioscience, Ampel BioSolutions, Selecta Biosciences, Arthrosi Therapeutics [...]

M2 PRESSWIRE-November 8, 2022-: Systemic Lupus Erythematosus (SLE) Market to Register Incremental Growth During the Forecast Period (2022-32), Asserts DelveInsight | Key Companies - Xencor, Neovacs, Celgene, ILTOO, ImmuPharma (C)1994-2022 [...]

Tenders are invited for Repair maintenance of summer cooling repair maintenance of summer cooling appliances at various units under age i r and d kochi Doc Fees : INR 500.00 [...]

OSAKA, Japan: Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the signing of a research and development collaboration agreement with Ono Pharmaceutical Co. Ltd. [...]

SCHLIEREN, Switzerland & OSAKA, Japan -- Memo Therapeutics AG ('MTx'), an innovator in the field of antibody discovery and development, announced today the signing of a research and development collaboration [...]

China based Sony Hope Create Biotechnology(Beijing)Co.,Ltd has secured contract from Jilin medical college for Procurement of 2750-224KS22GJ031 Jilin Medical College 2022 Central Special Project-6-Jilin Provincial Neurological Chronic Disease Research and [...]

JICA has decided on the following 12 projects to be newly selected for SATREPS program in FY 2022. It is based on the selection results by committees of external experts [...]